Amicus Therapeutics
FOLD
#3320
Rank
S$5.68 B
Marketcap
S$18.37
Share price
0.00%
Change (1 day)
45.14%
Change (1 year)

Market capitalization of Amicus Therapeutics (FOLD)

Market cap: S$5.68 Billion

As of January 2026 Amicus Therapeutics has a market cap of S$5.68 Billion. This makes Amicus Therapeutics the world's 3320th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Amicus Therapeutics from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026S$5.68 B0.41%
2025S$5.65 B44.68%
2024S$3.91 B-28.83%
2023S$5.49 B19.5%
2022S$4.59 B5.7%
2021S$4.35 B-45.34%
2020S$7.96 B137.33%
2019S$3.35 B35.32%
2018S$2.47 B-22.55%
2017S$3.20 B212.58%
2016S$1.02 B-40.32%
2015S$1.71 B63.3%
2014S$1.05 B469.3%
2013S$0.18 B13.44%
2012S$0.16 B5.36%
2011S$0.15 B-26.1%
2010S$0.20 B65.33%
2009S$0.12 B-50.2%
2008S$0.25 B-26.23%
2007S$0.34 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Amicus Therapeutics was reported to be:

S$5.66 Billion
by Nasdaq info icon info icon
S$5.68 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
S$35.40 B 523.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$14.56 B 156.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$1.18 B-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$131.00 B 2,205.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
S$0.54 B-90.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$336.16 B 5,816.48%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark